Wed.Mar 06, 2024

article thumbnail

HHS Says It’s Working to Help Those Impacted by Change Healthcare Cyberattack

Drug Topics

The statement says the agency is talking with CMS to initiate new flexibilities, but multiple advocacy groups have said it’s not nearly enough.

201
201
article thumbnail

Florida health officials provide scant details on measles cases, worrying health experts

STAT

On Sunday, public health officials in two Michigan counties warned their residents that they may have been exposed to measles. In Wayne County , an adult who had contracted the virus abroad had been in health-related settings in Dearborn on two days last week — two urgent care clinics, a CVS pharmacy, and a hospital emergency department. Health officials in neighboring Washtenaw County issued a similar alert about a different case — also an adult, also infected abroad —

Hospitals 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AstraZeneca pledges £650M in UK investments to boost vaccine capabilities, expand near HQ

Fierce Pharma

AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing a big chunk of money into the Big Pharma’s home country. | AstraZeneca CEO Pascal Soriot, who has been critical of the U.K.’s business environment for the life sciences industry, is directing £650 million into the Big Pharma’s home country.

Vaccines 145
article thumbnail

Microplastics found in blood vessels linked to greater risk of heart problems, study finds

STAT

Micro and nanoplastics, tiny pieces of plastic scattered throughout the environment, have been increasingly found to be able to enter the body, raising questions about where they end up and how they affect people’s health. In a new study, researchers say they have for the first time detected these plastic pieces inside fatty plaques that accumulate in blood vessels and linked them to an increased rate of heart problems.

145
145
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Antipsychotic Prescribing Patterns in Pediatric Patients with Major Depressive Disorder

Pharmacy Times

Findings emphasize the importance of further research on effective and safe alternative treatments for MDD in children and adolescents, specifically in patients who are refractory to nonpharmacologic treatment and/or standard of care antidepressants

145
145
article thumbnail

Biden to propose expanding Medicare drug price negotiation in State of the Union

STAT

WASHINGTON — President Biden wants to more than double the size of Medicare’s new drug price negotiation program and will preview the plan in his State of the Union address, the White House announced Wednesday. While the current program will eventually allow Medicare to negotiate the prices of up to 20 drugs per year, Biden will propose increasing that number to 50, and bringing more drugs into the negotiation process sooner.

143
143

More Trending

article thumbnail

Under new management, and under the cloud of the Change hack, HIMSS24 kicks off in Orlando next week

Fierce Healthcare

One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall. | One of the largest health IT conferences, HIMSS24, will kick off in Orlando on Monday as a revamped trade show following a deal with Informa Markets last fall.

143
143
article thumbnail

Opinion: The CDC’s new, relaxed Covid isolation guidance makes perfect sense

STAT

What makes for good public health guidance? That’s the conversation I was having with a colleague in her 40s railing against the Centers for Disease Control and Prevention’s erstwhile guidance about alcohol consumption for women of “childbearing” years. The guidance, if followed closely, would mean that all women ages 15 to 49 should fully abstain from alcohol consumption unless they’re using birth control.

143
143
article thumbnail

Pharmacy Focus: Limited Series - Celebrity Endorsements in Vaccine Hesitancy

Pharmacy Times

This episode highlights how celebrity endorsements and local influencers can be leveraged to address vaccine hesitancy by shaping attitudes, but also must account for factors like audience trust and the potential for both benefits and limitations.

Vaccines 139
article thumbnail

STAT+: Oracle Health chair says Cerner isn’t competing with Epic

STAT

Cerner may have ceded U.S. business to reigning electronic health records market leader Epic Systems, but new owner Oracle plans to close the gap with cloud services from supply chain management to claims processing, a top Oracle Health executive tells STAT.  Epic and Cerner have long been in a head-to-head race for medical software contracts. The playing field changed in 2022 when Cerner merged with cloud titan Oracle , coinciding with a loss in its large health system customers in the U.S

Cerner 142
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The growing uses of medicinal cannabis

Pharmaceutical Technology

Demand for medicinal cannabis is increasing globally to treat a range of illnesses and conditions.

136
136
article thumbnail

FDA Grants Breakthrough Device Designation for Phospho-Tau 217 to Help Detect AD

Pharmacy Times

The device conducts blood biomarker tests that accurately diagnose amyloid pathology and can assist in diagnosing Alzheimer disease in patients with cognitive impairment.

FDA 131
article thumbnail

Startup Alumis raises $259 million as it prepares for psoriasis trial

STAT

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis. Alumis announced its Series C round Wednesday and plans to move its lead drug into Phase 3 trials. Venture firm Foresite Capital, which incubated Alumis, co-led the financing with Samsara BioCapital and venBio Partners.

131
131
article thumbnail

How providers are leveraging patient engagement tools to close gaps in cancer screenings

Fierce Healthcare

Millions of cancer screenings were missed during the COVID-19 pandemic. | Cancer is the second leading cause of death in the U.S. As providers try to get more patients into preventive screenings, they lean on patient engagement tools to reach them.

131
131
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Opinion: Charging patients to message their doctors mostly benefits major hospital systems

STAT

Thinking about messaging your physician about a weird rash? You may want to hold off on it. Some hospital systems have started charging patients for digital messages to their doctors via the electronic medical record, either a flat rate (like a copay) or on sliding scale depending on the time or complexity of the physician’s response. Sometimes it’s billed through an insurer, sometimes as a direct cost to the patient.

Hospitals 129
article thumbnail

Federal regulators, clinicians make their case against private equity in healthcare

Fierce Healthcare

Federal regulators are weighing new safeguards against exploitative dealmaking by private equity firms within healthcare—and, so far, they aren't signaling any reprieve for the corporate investors | FTC, DOJ and HHS heads were receptive to testimonies given by providers and researchers Tuesday on the need for policy changes addressing private equity practices within the healthcare industry.

128
128
article thumbnail

Pharmacists Take the Lead When Monitoring Patients with Multisensor Implantable Cardioverter Defibrillators

Pharmacy Times

Findings showed that pharmacists frequently communicated with patients to implement complex plans.

article thumbnail

12 Questions with Jorge Reis-Filho

pharmaphorum

Get to know Jorge Reis-Filho, Vice President of Cancer Biomarker Development at AstraZeneca, through this exclusive interview featuring 12 insightful questions. Gain insights into his role, career journey, and the latest advancements in cancer biomarker development.

119
119
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Small Vessel Disease, Amyloid Pathology Can Independently Reduce Cognition in Adults With T2D

Pharmacy Times

Diabetes is a known risk factor for cognitive decline and small vessel disease.

123
123
article thumbnail

STAT+: With Meta’s backing, Headspace launches into VR

STAT

Headspace, which has built a growing digital health business around mindfulness, is joining forces with Meta to launch a meditation app for Quest, the social media giant’s virtual reality headset. Called Headspace XR, the newly launched VR app — developed with funding from Meta — guides users through meditation and other activities, like a Tai Chi-inspired movement game, meant to encourage mental wellbeing.

118
118
article thumbnail

Vitamin D May Prolong ‘Honeymoon Phase’ of Type 1 Diabetes in Patients With Recent Diagnosis

Pharmacy Times

Vitamin D preserved insulin-producing cells and cell function, which can reduce complications in young patients.

122
122
article thumbnail

Automation of literature search and review

pharmaphorum

Looking to automate your literature search and review process in pharmacovigilance? Learn how AI can streamline the detection and analysis of Adverse Events (AE) effectively.

116
116
article thumbnail

WHO flags increasing resistance to GSK's HIV med Tivicay in some countries

Fierce Pharma

GSK's antiretroviral HIV medicine Tivicay (dolutegravir) has been recommended by the World Health Organization since 2018 as a preferred treatment for the virus. | The World Health Organization (WHO)'s latest HIV Drug Resistance report showed that some patients are developing resistance to Tivicay, which has been recommended as a preferred treatment since 2018.

115
115
article thumbnail

Sandoz U.S. subsidiaries resolve generic drug antitrust class action litigation with direct purchaser class plaintiffs

Drug Store News

Sandoz U.S. to pay $265 million in exchange for full release of all claims by the class.

111
111
article thumbnail

UK Chancellor trumpets £650m AstraZeneca investment

pharmaphorum

A £650 million investment package by AstraZeneca in the UK has been held up by Chancellor Jeremy Hunt as a “vote of confidence” in the country’s life sciences sector. AZ is preparing to invest £450 million at its manufacturing site in Speke, Liverpool, to boost research, development and manufacturing of vaccines, including the construction of a new plant that will be powered by renewable energy, according to a government statement.

Packaging 111
article thumbnail

UPMC reports almost $200M operating loss as expenses rise

Fierce Healthcare

Pittsburgh-based UPMC, a 40-hospital system, has reported a 2023 operating loss of $198.3 million (-0.7% operating margin) on r | Pittsburgh-based UPMC, a 40-hospital system, has reported a 2023 operating loss of $198.3 million on revenue of $27.7 billion.

Hospitals 109
article thumbnail

Amid patent fight, Sandoz biosimilars to Amgen bone blockbusters gain FDA nods

Fierce Pharma

Two biosimilars to Amgen’s lucrative bone drugs Prolia and Xgeva have clinched approvals at the FDA, though ongoing patent litigation makes launch timing uncertain. | Sandoz has clinched FDA approvals for biosimilars to Amgen’s denosumab. Sandoz’s drugs mark the first approved denosumab biosimilars and treat all indications of the reference products.

FDA 105
article thumbnail

NICE no follows Scottish aye for rare disease drug Xenpozyme

pharmaphorum

NICE has turned down Sanofi’s Xenpozyme as a treatment for the rare disease acid sphingomyelinase deficiency (ASMD), creating a situation where access to the drug in the UK will depend on a patient’s address.

105
105
article thumbnail

New radiopharmaceutical laboratory opens in Germany

European Pharmaceutical Review

Ariceum Therapeutics has opened its new laboratory facilities at its Berlin headquarters. This allows in-house R&D for its next generation radiopharmaceutical pipeline candidates and support in the transfer of advancing products into the clinic. There is over ~200m² of laboratory space (cold biology/chemistry lab; radioactive lab) at the new site.

article thumbnail

Sandoz gets first FDA OK for denosumab biosimilars

pharmaphorum

Sandoz has claimed the first FDA approvals for biosimilars of Amgen’s blockbuster bone disease therapy denosumab, but has not said when it plans to launch them onto the US market.

FDA 105
article thumbnail

How Long Will the Current Slowdown in Biotech Investment Last?

Pharmaceutical Commerce

In this Pharmaceutical Commerce video interview, Emma Banks, CEO of ramarketing, discusses how the balance between onshoring and outsourcing will evolve, how long will the current slowdown in biotech investment likely last, and what factors might influence its duration.

105
105
article thumbnail

Naked Sunday’s SPF cosmetics hit Target shelves

Drug Store News

Target carries an assortment of Naked Sundays’ product lines and two exclusive new launches.

105
105
article thumbnail

Bayer CEO pulls back from breakup of ‘badly broken’ group

pharmaphorum

Bayer CEO says company is “badly broken” by patent losses, litigation, debt levels, and bureaucracy, limiting its options for a break-up of the group.

105
105